Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Letrozole × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 116 Endometrial Neoplasms 15 Neoplasm Metastasis 8 Ovarian Neoplasms 7 Neoplasms 7 Polycystic Ovary Syndrome 6 Fallopian Tube Neoplasms 4 Advanced Breast Cancer 4 Triple Negative Breast Neoplasms 3 Recurrence 3 Prostatic Neoplasms 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Neoplasms, Male 3 Squamous Cell Carcinoma of Head and Neck 2 Progesterone Resistance 2 Neoplasms by Site 2 Infertility 2 Hereditary Sensory and Autonomic Neuropathies 2 Head and Neck Neoplasms 2 HR+/HER2- Breast Cancer 2 Endometrial Hyperplasia 2 Cystadenocarcinoma, Serous 2 Carcinoma, Non-Small-Cell Lung 2 Breast Diseases 2 Breast Cancer Metastatic 2 Breast Cancer Female 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Small Cell Lung Carcinoma 1 Peritoneal Neoplasms 1

Interventions

Cyclophosphamide 13 blinatumomab 8 fludarabine phosphate 7 fludarabine 7 venetoclax 6 Cytarabine 6 Rituximab 5 Lenalidomide 5 Dexamethasone 4 Blood Specimen Collection 4 Azacitidine 4 obinutuzumab 3 daratumumab 3 Radiotherapy 3 Melphalan 3 Immunotherapy, Adoptive 3 pembrolizumab 2 nilotinib 2 Vincristine 2 Methotrexate 2 Imatinib Mesylate 2 Idarubicin 2 Daunorubicin 2 Dasatinib 2 Chemotherapy, Adjuvant 2 Capecitabine 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡